No Detail Found!

Comparison of Serum Visfatin Levels in Post-Menopausal Pakistani Women with and Without Breast Carcinoma

Author(s)
Lubna Gohar Department of Physiology, Army Medical College/National University of Medical Sciences (NUMS) Rawalpindi Pakistan
Umbreen Ahmed Department of Physiology, Army Medical College/National University of Medical Sciences (NUMS) Rawalpindi Pakistan
Nadeem Zafar Department of Histopathology, Armed Forces Institute of Pathology/National University of Medical Sciences (NUMS) Rawalpindi Pakistan,
Mansoor Wahid Department of Oncology, Prince Sultan Military Medical City, Riyadh, Saudi Arabia
Shoaib bin Aleem Department of Physiology, Army Medical College/National University of Medical Sciences (NUMS) Rawalpindi Pakistan
Shazia Junaid Department of Physiology, Army Medical College/National University of Medical Sciences (NUMS) Rawalpindi Pakistan
Abstract
Objective: To compare serum Visfatin levels in Pakistani post-menopausal women having breast carcinoma with healthy women. Study Design: Comparative cross-sectional study. Place and Duration of Study: Physiology Department, Army Medical College, in collaboration with Armed Forces Institute of Pathology, Rawalpindi, Pakistan, from Dec 2019 to Dec 2020. Methodology: Eighty post-menopausal Pakistani women were included, out of which forty women were post-menopausal newly diagnosed and histologically confirmed cases of breast carcinoma awaiting their treatment. Menopause was confirmed through interviews and relevant history. Serum Visfatin levels were determined using an enzyme-linked immunosorbent assay (ELISA). Result: Mean serum Visfatin levels were significantly higher in the Breast Carcinoma-Group (28.14±8.17 ng/ml) compared to the Healthy Control-Group (13.64±1.07 ng/ml). Moreover, serum Visfatin levels correlated positively with weight (r=0.735), body mass index (r=0.678), waist circumference(r=0.295) and waist-to-hip ratio (r=0.220). Conclusion: Serum Visfatin levels were markedly elevated in post-menopausal women with breast carcinoma as compared to Healthy Controls. Higher serum Visfatin may be regarded as a potential risk factor in the development of breast carcinoma.
Publication Details
Page(s) 1858-1861
Published Journal: Pakistan Armed Forces Medical Journal, Volume: 73, Issue: 6, Year: 2023

Request the full text from PASTIC

Keywords
Obesity, breast carcinoma, Menopause, Visfatin.
0

Citations

0

Downloads

61

Views